We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Preventive Measures Result in Fewer DVT’s

By HospiMedica International staff writers
Posted on 08 Jun 2014
A new study indicates that the odds of postoperative deep vein thrombosis (DVT) steadily declined after the implementation of a multicomponent prevention program.

Researchers at Boston University School of Medicine (MA, USA) and Boston Medical Center (BMC; MA, USA) developed a strategy to decrease venous thromboembolism (VTE) complications, based on standardized electronic physician orders that specify early postoperative mobilization and mandatory VTE risk stratification for every patient, using the Caprini grading system. More...
The derived scores dictate the nature and duration of VTE prophylaxis, including on an outpatient basis.

The VTE prevention program placed an emphasis on early postoperative mobilization (walking three times a day, starting on the day of the operation). Additional components included standardized risk assessment using five categories of VTE risk; risk-based prophylaxis involving inflatable pressure boots and/or low doses of anticoagulants; electronic physician orders that specified appropriate preventive treatment; and patient education. The researchers also monitored physicians’ adherence to the automated recommendations.

The results of the study showed that the incidence of DVT decreased by 84% (from 1.9% to 0.3%) with the implementation of VTE prevention efforts, while pulmonary emboli incidence fell by 55% (from 1.1% to 0.5%). The risk-adjusted VTE outcomes steadily declined from an odds ratio of 3.41 to 0.94. The surgeons' compliance rates ranged from 100% for patients at low or moderate risk for a VTE to 77% for patients in the highest risk category. The study was published in the June 2014 issue of the Journal of the American College of Surgeons.

“A patient care program, emphasizing early postoperative mobilization along with mandatory VTE risk stratification and commensurate electronic prophylaxis recommendations, significantly reduced the likelihood of VTE complications among our patients,” concluded coauthor David McAneny, MD, FACS, vice chair of surgery at BMC. “We are encouraged by the success in reducing the frequency of these devastating events among our patients by implementing this prevention program.”

VTE is a significant cause of mortality, long-term disability and chronic ill-health problems, and are caused mainly by a combination of venous stasis and hypercoagulability, but to a lesser extent also by endothelial damage and activation. One in 20 people will have a VTE at some time in their life and the risk increase with age. It is estimated that as many as half of all cases of VTE are associated with hospitalization for medical illness or surgery.

Related Links:

Boston University School of Medicine
Boston Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.